SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme Journal Article


Authors: Békés, M.; Rut, W.; Kasperkiewicz, P.; Mulder, M. P. C.; Ovaa, H.; Drag, M.; Lima, C. D.; Huang, T. T.
Article Title: SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme
Abstract: Ubiquitin (Ub) and the Ub-like (Ubl) modifier interferonstimulated gene 15 (ISG15) participate in the host defence of viral infections. Viruses, including the severe acute respiratory syndrome human coronavirus (SARS hCoV), have co-opted Ub-ISG15 conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of Ub-ISG15-conjugated host proteins. In the present study, we compare substrate specificities of the papain-like protease (PLpro) from the recently emerged Middle East respiratory syndrome (MERS) hCoV to the related protease from SARS, SARS PLpro. Through biochemical assays, we show that, similar to SARS PLpro, MERS PLpro is both a deubiquitinating (DUB) and a deISGylating enzyme. Further analysis of the intrinsic DUB activity of these viral proteases revealed unique differences between the recognition and cleavage specificities of polyUb chains. First,MERS PLpro shows broad linkage specificity for the cleavage of polyUb chains, whereas SARS PLpro prefers to cleave Lys48-linked polyUb chains. Secondly, MERS PLpro cleaves polyUb chains in a 'mono-distributive' manner (one Ub at a time) and SARS PLpro prefers to cleave Lys48-linked polyUb chains by sensing a di-Ub moiety as a minimal recognition element using a 'di-distributive' cleavage mechanism. The di-distributive cleavage mechanism for SARS PLpro appears to be uncommon among USP (Ub-specific protease)-family DUBs, as related USP family members from humans do not display such a mechanism. We propose that these intrinsic enzymatic differences between SARS and MERS PLpro will help to identify pro-inflammatory substrates of these viral DUBs and can guide in the design of therapeutics to combat infection by coronaviruses. © The Authors Journal compilation © 2015 Biochemical Society.
Keywords: controlled study; unclassified drug; human cell; nonhuman; ubiquitin; protein function; transcription factor; protein interaction; molecular recognition; enzyme specificity; enzyme substrate complex; protein cross linking; lysine; protein cleavage; protein modification; nucleic acid binding protein; biochemical analysis; virus enzyme; coronavirus; sars coronavirus; human; female; priority journal; article; hela cell line; deubiquitinating enzymes; deubiquitinase; interferon-stimulated gene 15 (isg15); papain-like protease (plpro); middle east respiratory syndrome (mers); severe acute respiratory syndrome (sars); interferon stimulated gene 15; middle east respiratory syndrome coronavirus papain like protease; severe acute respiratory syndrome coronavirus papain like protease; deubiquitination; middle east respiratory syndrome coronavirus
Journal Title: Biochemical Journal
Volume: 468
Issue: 2
ISSN: 0264-6021
Publisher: Portland Press Ltd  
Date Published: 2015-06-01
Start Page: 215
End Page: 226
Language: English
DOI: 10.1042/bj20141170
PROVIDER: scopus
PMCID: PMC4447217
PUBMED: 25764917
DOI/URL:
Notes: Export Date: 3 August 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christopher D Lima
    103 Lima